Seek truth from facts, competitive symbiosis
Hunan Zhengqing Pharmaceutical Group Co., Ltd. Special Report on the Deposit and Use of Raised Funds for the Year 2019
Category:
Release time:
2020-05-20
Hunan Zhengqing Pharmaceutical Group Co., Ltd. (hereinafter referred to as "the Company" ) The Board of Directors, in accordance with the "Administrative Measures for the Supervision and Management of Non-Listed Public Companies" and other relevant laws, regulations, and normative documents, prepared a special report on the deposit and use of raised funds as of 2019 year 12 month 31 a special report on the deposit and use of raised funds by the Company. ：
I. Basic Information on Funds Raised from Share Issuance
(I) Amount and Arrival Time of Raised Funds
The Company's 2019 year 7 month 27 date Sixth Board of Directors Third Meeting, 2019 year 8 month 12 date 2019 the second extraordinary general meeting of shareholders in year approved the "Proposal on the Company's 2019 First Private Placement Plan of Shares in year".
The Company ultimately issued shares to Wu Feichi and Liu Yunjun, issuing shares 17,964,071 shares, with the final share issue price being RMB per share 1.67 yuan, and the total amount of raised funds being 3,000.00 ten thousand yuan. The aforementioned raised funds were fully in place on 2019 year 11 month 13 date, verified by ZhongShen ZhongHuan Certified Public Accountants (Special General Partnership) Zhong Huan Yan Zi (2019) No. 110005 "Capital Verification Report".
The Company has, in accordance with 2019 year 8 month 13 approved by the Fourth Meeting of the Sixth Board of Directors on date, the "Management System for Raised Funds," implemented a dedicated account storage system for raised funds, and stipulated regulations for the deposit, use and so on, and supervision of the use and changes of funds.
In accordance with the "Management System for Raised Funds," the Company the established a special account for raised funds for this issuance as stipulated, ， specifically for depositing and managing raised funds. The specific account information is as follows:
|
Account Name |
Hunan Zhengqing Pharmaceutical Group Co., Ltd. |
|
Opening Bank |
China Construction Bank Co., Ltd. Huaihua City Branch Yinjian Sub-branch |
|
Account |
43050172903700000616 |
(II) Use of Raised Funds
According to the Company's disclosed " Private Placement Prospectus ", the purpose of the funds raised from this share issuance is: to supplement working capital. As of 2019 year 12 month 31 date, the actual use of raised funds is as follows:
|
Item |
Amount (Yuan) |
|
1 , Total Raised Funds |
30,000,000.00 |
|
Add: Net interest income after deducting handling fees |
5,306.47 |
|
Original account balance |
600.00 |
|
2 , Net Raised Funds |
30,005,906.47 |
|
3 , Actual Use of Raised Funds |
29,990,000.00 |
|
Less: Supplement working capital |
29,990,000.00 |
|
4 , As of 2019 year 12 month 31 date, Balance of Raised Funds |
15,906.47 |
II. Management of Raised Funds
2019 year 11 month, the Company, China Construction Bank Co., Ltd. Huaihua City Branch Yinjian Sub-branch, and CSC Financial Co., Ltd. jointly signed the "Three-Party Supervision Agreement for Raised Funds," opened a special account for raised funds, and transferred a total of 3 0,000,000.00 yuan entirely into the Company's special raised funds account. The Company strictly supervises and manages the use of raised funds in accordance with existing regulatory rules and normative documents, ensuring that the raised funds are used strictly according to the purposes specified in the "Private Placement Prospectus." There is no situation where controlling shareholders, actual controllers, or other related parties occupy or transfer the funds raised from this private placement.
III. Use of Funds for Changed Raised Fund Investment Projects
The Company has no instances of changing raised fund investment projects.
IV. Concluding Opinions on the Company's Deposit and Actual Use of Raised Funds
The Company's deposit and actual use of raised funds comply with the "Company Law," "Securities Law," "Administrative Measures for the Supervision and Management of Non-Listed Public Companies," "Regulatory Q&A for Non-Listed Public Companies —Private Placement (I)" and other relevant laws, regulations, and normative documents, with no non-compliant deposit or use of raised funds.
Hunan Zhengqing Pharmaceutical Group Co., Ltd.
Board of Directors
2020 year 5 month 14 date
Copyright Hunan Zhengqing Pharmaceutical Group Co., Ltd.
Virtual Showroom：
Agent：
OA：
CRM：
在线客服添加返回顶部
右侧在线客服样式 1,2,3 1
图片alt标题设置： Hunan Zhengqing Pharmaceutical Group Co., Ltd.
表单验证提示文本： Please enter correct content!
循环体没有内容时： Updating......
CSS / JS 文件放置地